Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report
F Collette, M Hamoir, P Van Eeckhout… - Clinical case …, 2020 - Wiley Online Library
Clinical case reports, 2020•Wiley Online Library
Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm
involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic
treatment of locally advanced or metastatic PCAC. Anti‐androgen therapy may have activity
in inoperable or metastatic PCAC with high androgen receptor (AR) expression.
involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic
treatment of locally advanced or metastatic PCAC. Anti‐androgen therapy may have activity
in inoperable or metastatic PCAC with high androgen receptor (AR) expression.
Abstract
Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti‐androgen therapy may have activity in inoperable or metastatic PCAC with high androgen receptor (AR) expression.
Wiley Online Library以上显示的是最相近的搜索结果。 查看全部搜索结果